Contemporary Breast Imaging and Concordance Assessment: A Surgical Perspective

Surgical Clinics of North America

Volumn 91, Issue 1, 2011, Pages 33-58

  Landercasper, Jeffrey ^a,b,c   Linebarger, Jared H ^a  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Patient Quality Committee   (United States)

Author keywords

Breast; Concordance; Magnetic resonance imaging; Mammography; Quality measures; Surgeons; Ultrasonography

Indexed keywords

BREAST CANCER; BREAST CARE; BREAST EXAMINATION; BREAST IMAGING; BREAST SELF EXAMINATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECHOMAMMOGRAPHY; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SURGEON;

BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; ULTRASONOGRAPHY, MAMMARY;

EID: 78650281838     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2010.10.003     Document Type: Review

References (123)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics 2010. CA Cancer J Clin 2010, 60:277-300. 10.1002/caac.20073.
2. Silverstein M.J., Recht A., Lagios M.D., et al. Image-detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg 2009, 209:504-520.
3. Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl Cancer Inst Monogr 1997, 22:27-30.
4. Baker L.H. Breast cancer detection demonstration project: five-year summary report. CA Cancer J Clin 1982, 32:194-225.
5. Beahrs O.H., Shapiro S., Smart C.R. Report of the Working Group to review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 1979, 62(3):639-709.
6. Smart C.R., Byrne C., Smith R.A., et al. Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1997, 47(3):134-149.
7. Tabar L., Vitak B., Chen H.H., et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001, 91(9):1724-1731.
8. Tabar L., Vitak B., Chen H.H., et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000, 38:625-651.
9. Byrne C., Smart C.R., Chu K.C., et al. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project. Cancer 1994, 74(Suppl 1):301-310.
10. Cunningham M.P. The Breast Cancer Demonstration Detection Project 25 years later. CA Cancer J Clin 1997, 47(3):131-133.
11. Duffy S.W., Tabar L., Smith R.A. The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA Cancer J Clin 2002, 52(2):68-71.
12. Seidman H., Gelb S.K., Silverberg E., et al. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1987, 37(5):258-290.
13. ACR Practice Guideline for the Performance of Screening and Diagnostic Mammography Res 24 Available at:, Accessed June 21, 2009. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast/Screening_Diagnostic.aspx(ACR).
14. Position statement on USPSTF Available at:, Accessed July 17, 2010. http://www.breastcare.org.
15. Screening mammography indications Available at:, Accessed July 17, 2010. http://www.breastsurgeons.org.
16. Screening mammography indications Available at:, Accessed July 17, 2010. http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_Can_breast_cancer_be_found_early_5.asp(ACS).
17. Breast cancer screening and diagnosis guidelines Available at:, Accessed July 17, 2010. http://www.nccn.org.
18. Smith R.A., Cokkinides V., Brooks D., et al. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010, 60(2):99-119.
19. US Preventive Task Force Screening for breast cancer: US Preventive Task Force Recommendation Statement. Ann Intern Med 2009, 151(10):716-726.
20. Armstrong K., Moye E., Williams S., et al. Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007, 146(7):516-526.
21. Djulbegovic B., Lyman G.H. Screening mammography at 40-49 years: regret or no regret?. Lancet 2006, 368(9522):2035-2037.
22. Keen J.D., Keen J.E. What is the point: will screening mammography save my life?. BMC Med Inform Decis Mak 2009, 9:18.
23. Kopans D.B. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2002, 94(2):580-581. Comment on: Cancer 2001;1;91(9):1724-3, [author reply: 581-3].
24. Moss S.M., Cuckle H., Evans A., et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006, 368:2053-2060.
25. Whitman G.J. The role of mammography in breast cancer prevention. Curr Opin Oncol 1999, 11(5):414-418.
26. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. American Cancer Society Breast Cancer Advisory Group. CA Cancer J Clin 2007, 57(2):75-89.
27. Jackson V.P. Diagnostic mammography. Radiol Clin North Am 2004, 42(5):853-870. vi.
28. Homer M.J., Berlin L. Radiography of the surgical breast biopsy specimen. AJR Am J Roentgenol 1998, 171:1197-1199.
29. Jackman R.J., Marzoni F.A. Needle-localised breast biopsy: why do we fail?. Radiology 1997, 204:677-684.
30. ACR practice guideline for the performance of stereotactically guided breast interventional procedures (Revised) Res 28 Available at:, Accessed June 21, 2009. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast.aspx.
31. Performance and practice guidelines for stereotactic breast procedures Available at:, Accessed July 7, 2010. http://www.breastsurgeons.org/statements/index.php.
32. Stomper P.C., Budnick R.M., Stewart C.C. Use of specimen mammography-guided FNA (fine-needle aspirates) for flow cytometric multiple marker analysis and immunophenotyping in breast cancer. Cytometry 2000, 42(3):165-173.
33. McCormick J.T., Keleher A.J., Tikhomirov V.B., et al. Analysis of the use of specimen mammography in breast conservation therapy. Am J Surg 2004, 188(4):433-436.
34. Popli M.B. Pictorial essay: mammographic features of breast cancer. Indian J Radiol Imaging 2001, 11:175-179.
35. Sickles E.A. Mammographic features of 300 consecutive non-palpable breast cancers. AJR Am J Roentgenol 1986, 146:661-676.
36. Muller-Schimpfle M., Wersebe A., Xydeas T., et al. Microcalcifications of the breast: how does radiologic classification correlate with histology?. Acta Radiol 2005, 46(8):774-781.
37. D'Orsi C., Bassett L., Berg W., et al. ACR Breast Imaging Reporting and Data System (BI-RADS Atlas) 2003, American College of Radiology, Reston (VA). 4th edition.
38. D'Orsi C.J., Kopans D.B. Mammography interpretation: the BI-RADS method. Am Fam Physician 1997, 55:1548-1550. 52.
39. Balleyguier C., Ayadi S., Van Nguyen K., et al. BI-RADS classification in mammography. Eur J Radiol 2007, 61(2):192-194.
40. Hirunpat S., Tanomkiat W., Khojarern R., et al. Accuracy of the mammographic report category according to BI-RADS. J Med Assoc Thai 2005, 88(1):62-65.
41. Lacquement M.A., Mitchell D., Hollingsworth A.B. Positive predictive value of the Breast Imaging Reporting and Data System. J Am Coll Surg 1999, 189(1):34-40.
42. Liberman L., Abramson A.F., Squires F.B., et al. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol 1998, 171(1):35-40.
43. Mammography teaching files Available at:, Accessed July 17, 2010. http://www.rad.washington.edu/academics/academic-sections/mbi/education/mammoed/teaching-files.
44. Mammography teaching files Available at:, Accessed July 17, 2010. http://www.radiologyeducation.com/%23RadiologyTeachingFiles.
45. Ng K.H., Muttarak M. Advances in mammography have improved early detection of breast cancer. J HK Coll Radiol 2003, 6:126-131.
46. ACR Committee on quality assurance. American College of Radiology (ACR) mammography quality control manual for radiologists, radiologic technologists, and medical physicists 1999, American College of Radiology, Reston (VA).
47. Hendrick R.E., Bassett L., Botsco M.A., et al. Mammography quality control manual 1999, American College of Radiology, Reston (VA).
48. MQSA Mammography Quality Standards Act Available at:, Accessed July 17, 2010. http://www.fda.gov/cdrh/mammography.
49. Skaane P., Hofvind S., Skjennald A. Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. Radiology 2007, 244(3):708-717.
50. Van Ongeval C., Bosmans H., Van Steen A. Current status of digital mammography for screening and diagnosis of breast cancer. Curr Opin Oncol 2006, 18(6):547-554.
51. Stomper P.C., Margolin F.R. Ductal carcinoma in situ: the mammographer's perspective. AJR Am J Roentgenol 1994, 162:585-591.
52. Feig S.A. Ductal carcinoma in situ: implications for screening mammography. Radiol Clin North Am 2000, 38:653-668.
53. Breast Cancer Surveillance Consortium Available at:, Accessed July 17, 2010. http://breastscreening.cancer.gov/.
54. Weaver D.L., Rosenberg R.D., Barlow W.E., et al. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006, 106(4):732-742.
55. Tabar L., Tony Chen H.H., Amy Yen M.F., et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer 2004, 101(8):1745-1759.
56. Tabar L., Dean P.B. Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer. Breast Cancer Res 2008, 10(Suppl 4):S3.
57. Tabár L., Chen H.H., Duffy S.W., et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet 2000, 355(9202):429-433.
58. Zunzunegui R.G., Chung M.A., Oruwari J., et al. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?. Arch Surg 2003, 138(5):537-540.
59. Thompson M., Klimberg V.S. Use of ultrasound in breast surgery. Surg Clin North Am 2007, 87:469-484.
60. Thompson M., Henry-Tillman R., Margulies A., et al. Hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol 2007, 14(1):148-156.
61. Kopans D.B. Breast imaging 2007, Lippincott Williams & Wilkins, a Wolters Kluwer Business, Philadelphia, p. 555-606, 691-732, 783-888. 3rd edition.
62. Stavros A.T. Breast ultrasound 2004, Lippincott Williams & Wilkins, a Wolters Kluwer Business, Philadelphia, p. 16-41, 276-350, 445-528,528-96, 834-76.
63. Guideline for performance of a breast ultrasound examination Available at:, Accessed July 17, 2010. http://www.acr.org/secondarymainmenucategories/quality_safety/guidelines/breast/us_guided_breast.aspx.
64. American Society of Breast Surgeons position statements Available at:, Accessed July 17, 2010. http://breastsurgeons.org/statements/index.php.
65. NCCN indications for breast US in breast cancer screening and diagnosis guidelines Available at:, Accessed July 17, 2010. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
66. American College of Radiology BI-RADS Atlas for US Available at:, Accessed July 17, 2010. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BI-RADSAtlas/BI-RADSAtlasexcerptedtext/BI-RADSUltrasoundFirstEdition.aspx.
67. American College of Radiology US Lexicon Available at:, Accessed July 17, 2010. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/BI-RADSAtlas/BI-RADSAtlasexcerptedtext/BI-RADSUltrasoundFirstEdition.aspx.
68. Lazarus M., Mainiero M.B., Schepps B., et al. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 2006, 239:385-391.
69. Bruening W., Fontanarosa J., Tipton K., et al. Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med 2010, 1152(4):238-246.
70. Bruening W., Schoelles K., Treadwell J., et al. Comparative effectiveness of core-needle and open surgical biopsy for the diagnosis of breast lesions. Comparative effectiveness review No. 19. (Prepared by ECRI Institute Evidence-based Practice Center under Contract No. 290-02-0019.) 2009, Agency for Healthcare Research and Quality, Rockville (MD), Available at:, Accessed December 15, 2009. http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.
71. Silverstein M. Where's the outrage?. J Am Coll Surg 2009, 208(1):78-79.
72. Pocock B., Taback B., Klein L., et al. Preoperative needle biopsy as a potential quality measure in breast cancer surgery. Ann Surg Oncol 2009, 16(5):1108-1111.
73. American Society of Breast Surgeons Mastery Program for quality measurement Available at:, Accessed July 26, 2010. http://www.breastsurgeons.org.
74. Landercasper J., Tafra L. The relationship between quality and cost during the perioperative breast cancer episode of care. Breast 2010, 19(4):289-296.
75. Golub R.M., Bennett C.L., Stinson T., et al. Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. J Clin Oncol 2004, 22(12):2430-2437.
76. Smith T.J., Landercasper J., Gundrum J.D., et al. Perioperative quality metrics for one step breast cancer surgery: a patient-centered approach. J Surg Oncol 2010, 102(1):34-38.
77. Kaufman C.S., Shockney L., Rabinowitz B., et al. Quality Initiative Committee. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol 2010, 17(2):377-385.
78. Landercasper J., Ellis R.L., Mathiason M.A., et al. A community breast center report card determined by participation in the National Quality Measures for Breast Centers ProgramTM. Breast J 2010, 16:472-780.
79. Genta F., Zanon E., Camanni M., et al. Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 2007, 31(6):1155-1163.
80. Cody H.S. One-step surgery for breast cancer: back to the future?. World J Surg 2007, 31(6):1153-1154.
81. Landercasper J., Gundersen S.B., Gundersen A.L., et al. Needle localization and biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet 1987, 164(5):399-403.
82. Ellis R.L. Interdisciplinary breast care: essential information for the treatment team. Semin Breast Dis 2005, 8(1):10-16.
83. American College of Radiology accreditation for US Available at:, Accessed July 17, 2010. http://www.acr.org/accreditation/breast.aspx.
84. Statement on training of non radiologists in performance and interpretation of imaging and image-guided biopsy Available at:, Accessed July 17, 2010. http://www.sbi-online.org/displaycommon.cfm%3Fan%3D4.
85. The American Institute of US Medicine (AIUM) breast cancer guidelines Available at:, Accessed July 17, 2010. http://www.aium.org/publications/guidelines.aspx.
86. American Society of Breast Surgeons certification criteria for surgeon sonography Available at:, Accessed July 17, 2010. http://www.breastsurgeons.org/certification/breast_ultrasound_certification.php.
87. NAPBC Program Standards Available at:, Accessed July 17, 2010. http://accreditedbreastcenters.org/standards/standards.html.
88. NCCN Guidelines for genetic/familial high-risk assessment: breast and ovarian Available at:, Accessed July 17, 2010. http://www.nccn.org.
89. NCCN Treatment guidelines for breast cancer Available at:, Accessed July 17, 2010. http://www.nccn.org.
90. Erkonen W.E., Smith W.L. Radiology 101: the basics and fundamentals of imaging 2010, Lippincott Williams & Wilkins, a Wolters Kluwer Business, Philadelphia, p. 8-10. 3rd edition.
91. MRI technology in Wikipedia Available at:, Accessed July 17, 2010. http://en.wikipedia.org/wiki/MRI.
92. Ellis R.L. Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle. Am J Roentgenol 2009, 193(6):1738-1740.
93. Lee C.H., Dershaw D.D., Kopans D., et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010, 7(1):18-27.
94. Orel S. Who should have breast magnetic resonance imaging evaluation?. J Clin Oncol 2008, 26(5):703-711.
95. Ciocchetti J.M., Joy N., Staller S., et al. The effect of magnetic resonance imaging in the workup of breast cancer. Am J Surg 2009, 198(6):824-828.
96. Hollingsworth A.B., Stough R.G., O'Dell C.A., et al. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008, 196(3):389-397.
97. Houssami N., Hayes D.F. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA Cancer J Clin 2009, 59(5):290-302.
98. de Bresser J., de Vos B., van der Ent F., et al. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 2010, 36(2):114-119.
99. Houssami N., Morrow M. Pre-operative breast MRI in women with recently diagnosed breast cancer-where to next?. Breast 2010, 19(1):1-2.
100. Katipamula R., Degnim A.C., Hoskin T., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009, 27(25):4082-4088.
101. Bleicher R.J., Ciocca R.M., Egleston B.L., et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 2009, 209(2):180-187. [quiz: 294-5]. Erratum appears in J Am Coll Surg 2009;209(5):679.
102. Siegmann K.C., Baur A., Vogel U., et al. Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer. Clin Radiol 2009, 64(4):403-413.
103. Solin L.J. Counterview: pre-operative breast MRI (magnetic resonance imaging) is not recommended for all patients with newly diagnosed breast cancer. Breast 2010, 19(1):7-9.
104. Morrow M. Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin N Am 2010, 19(3):475-492.
105. Demicheli R., Ardoino I., Boracchi P., et al. Ipsilateral breast tumour recurrence (IBTR) dynamics in breast conserving treatments with or without radiotherapy. Int J Radiat Biol 2010, 86(7):542-547.
106. Liau S.S., Cariati M., Noble D., et al. Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer. Ann R Coll Surg Engl 2010, 92:562-568.
107. Tuli R., Christodouleas J., Roberts L., et al. Prognostic indicators following ipsilateral tumor recurrence in patients treated with breast-conserving therapy. Am J Surg 2009, 198(4):557-561.
108. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Lancet 2005, 366(9503):2087-2106.
109. Tot T. Towards a renaissance of subgross breast morphology. Eur J Cancer 2010, 46(11):1946-1948.
110. Lagios M.D. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer 1977, 40(4):1726-1734.
111. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56(5):979-990.
112. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995, 333(22):1456-1461.
113. Fischer U., Baum F., Luftner-Nagel S. Preoperative MR imaging in patients with breast cancer: preoperative staging, effects on recurrence rates, and outcome analysis. Magn Reson Imaging Clin N Am 2006, 14(3):351-362. vi.
114. Solin L.J., Orel S.G., Hwang W.T., et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26(3):386-391.
115. Turnbull L.W., Brown S.R., Olivier C., et al. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). COMICE Trial Group. Health Technol Assess 2010, 14(1):1-182.
116. Landercasper J., Linebarger J.H., Ellis R.L., et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg 2010, 210(4):449-455.
117. Sorbero M.E., Dick A.W., Beckjord E.B., et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 2009, 16(6):1597-1605.
118. Newman E., Guest A., Helvie M., et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 2006, 107:2346-2351.
119. Masood S. Raising the bar: a plea for standardization and quality improvement in the practice of breast pathology. Breast J 2006, 12(5):409-412.
120. Kern K.A. The delayed diagnosis of breast cancer: medicolegal implications and risk prevention for surgeons. Breast Dis 2001, 12:145-158.
121. Tracy T.F., Crawford L.S., Krizek T.J., et al. When medical error becomes medical malpractice: the victims and the circumstances. Arch Surg 2003, 138:447-454.
122. Johnson N.B., Collins L.C. Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol 2009, 16(4):183-195.
123. Colloquium ASBD. Ensuring optimal interdisciplinary breast care in the United States: gaps, implications, and potential measures to assess optimal care early detection and diagnosis local-regional treatment systemic treatment. Copyright © 2009 American Society of Breast Disease. All rights reserved Available at:, Accessed July 17, 2010. http://www.asbd.org.